Founded by Hemangi Dhir, Be Clinical was established as a result of her personal experience with persistent dermatological concerns that conventional products failed to address. Motivated by this challenge, she pursued a scientific approach to skincare, formulating precise and effective solutions that rapidly garnered recognition through word-of-mouth. This led to the creation of Be Clinical-a brand dedicated to delivering targeted, results-driven anti-ageing solutions rooted in both nature and clinical science.
The newly secured funding will enable Be Clinical to internalise its manufacturing operations, thereby ensuring enhanced oversight of inventory, increased operational efficiency, and robust protection of proprietary formulations. This strategic initiative will also facilitate the brand’s entry into additional anti-ageing segments, expanding its portfolio of clinically validated solutions focused on skin longevity.
“Securing this investment is a strong validation of our vision. Anti-ageing has often been treated as an afterthought in skincare, but at Be Clinical, it’s our primary focus. We’re building a brand that addresses a real and growing need-especially among Indian Gen Z and Millennial consumers, who are now seeking targeted, effective solutions earlier in their skincare journey. I feel incredibly optimistic about the future and confident that Be Clinical will set a new standard for science-first, results-driven skincare in India,” said Hemangi Dhir, Founder of Be Clinical, in a statement.
